Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease

NCT06088433 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

292

Enrollment

OTHER

Sponsor class

Conditions

Coronary Heart Disease

Interventions

DRUG: Ticagrelor
DRUG: Clopidogrel
DRUG: Aspirin

Sponsor

Fu Wai Hospital, Beijing, China